This week’s post features Steve Bates, CEO of the BioIndustry Association, talking to Nigel Borshell of PharmaTelevision about the BIA’s involvement in the European Adaptive Licensing pilot project and the UK’s Early Access to Medicines Scheme, and how these initiatives can help companies find a new path to market or way to bring their drugs forward which will ultimately benefit patients.